- Home
- FHB vs CLDX Comparison
FHB vs CLDX Comparison
Compare FHB & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHB | CLDX |
|---|---|---|
| Founded | 1858 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.2B |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FHB | CLDX |
|---|---|---|
| Price | $25.61 | $38.78 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $27.00 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 1.6M | 694.0K |
| Earning Date | 04-24-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | ★ 22.91 | N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $880,788,000.00 | $12,743,000.00 |
| Revenue This Year | $7.00 | $111.39 |
| Revenue Next Year | $3.56 | $235.85 |
| P/E Ratio | $22.44 | ★ N/A |
| Revenue Growth | 8.94 | ★ 87.78 |
| 52 Week Low | $22.65 | $22.10 |
| 52 Week High | $30.58 | $45.14 |
Technical Indicators
Market Signals| Indicator | FHB | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 33.02 | 45.79 |
| Support Level | $25.09 | $28.51 |
| Resistance Level | $27.74 | $40.30 |
| Average True Range (ATR) | 0.43 | 1.37 |
| MACD | 0.02 | -0.35 |
| Stochastic Oscillator | 12.50 | 15.75 |
Price Performance
Historical ComparisonAbout FHB First Hawaiian Inc.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.